Lusso, Paolo
- National Institute of Allergy and Infectious Diseases (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #2,288
- Sustained Excellence
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2007 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$2.7M
Full award amounts, FY2023
Award Records
3
Records listing this PI
Award-Linked Rank
#2,288
By linked amount among FY2023 PIs
Earliest Year Loaded
2007
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Lusso, Paolo as a PI. Multi-PI records show the full award amount for context.
- 1ZIAAI001197-10ZIAContact PIStructure-Function Studies of the HIV-1 Envelope Glycoproteins and Development of a VLP-forming mRNA vaccine for HIV-1$1.8Maward amount
- 1ZIAAI000976-16ZIAContact PIRole of IL-7 and Integrin alpha4beta7 in Human Immunodeficiency Virus Infection$724.2Kaward amount
- 1ZIAAI001314-04ZIAContact PIPathogenesis studies on COVID-19 and development of a VLP-forming mRNA vaccine against SARS-CoV2$101.6Kaward amount
Award organization
Organizations that administered FY2023 awards listing Lusso, Paolo as a PI.
FY2023 award administered by National Institute of Allergy and Infectious Diseases ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2007First NIH AwardNational Institute of Allergy and Infectious Diseases
- 2007$500K Cumulative Funding
- 2007Entered Top 50% NationallyRanked #8270
- 2008$1M Cumulative Funding
- 2009$2M Cumulative Funding
- 2013$5M Cumulative Funding
- 2017$10M Cumulative Funding
- 2017Entered Top 25% NationallyRanked #3202
- 2018Entered Top 10% NationallyRanked #1973